InvestHub

Enanta Pharmaceuticals, Inc. (ENTA)

Enanta Pharmaceuticals, Inc. is a biotechnology firm dedicated to discovering and advancing small molecule therapies designed to combat a range of viral infections and various liver conditions. Its research and development efforts are primarily focused on addressing pathogens such as respiratory syncytial virus (RSV), SARS-CoV-2, human metapneumovirus (hMPV), and the hepatitis B virus (HBV).

Descriptive
Exchange
Industry
Country
Active:none
CompanyRating
Loading data…

Saved screens and full data - with a subscription

Subscribe to save filters and unlock all columns and ratings.

Subscribe - €24.90/mo